| Antinuclear antibodies in patients receiving non-practolol beta-blockers. | |
| | |
MedLine Citation:
|
PMID: 23197 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Antinuclear antibodies (ANA) were found in 54 (7.0%) out of 767 treated hypertensive patients compared with 59 (2.4%) out of 2470 healthy controls. Inclusion of a non-practolol beta-blocker in the treatment regimen did not significantly affect the incidence of ANA. ANA was found in significantly more patients being treated with methyldopa (13.0%) than patients receiving other hypotensive agents (3.8%). Non-practolol beta-blockers in combination with methyldopa did not increase the incidence of ANA further. |
| | |
Authors:
|
J D Wilson; J Y Bullock; D C Sutherland; C Main; K P O'Brien |
Related Documents
:
|
23714707 - Linear regression of postevacuation serum human chorionic gonadotropin concentrations p... 16736327 - Portal hypertension: contraindication to liver surgery? 7322327 - Intracranial pressure monitoring in severe pediatric near-drowning. 2142447 - Effects of amlodipine, a long-acting dihydropyridine calcium antagonist in aging hypert... 9227677 - Do chronic middle cerebral artery stenoses represent an embolic focus? a multirange tra... 6893837 - Late results following medial meniscectomy in an older population. |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: British medical journal Volume: 1 ISSN: 0007-1447 ISO Abbreviation: Br Med J Publication Date: 1978 Jan |
Date Detail:
|
Created Date: 1978-03-21 Completed Date: 1978-03-21 Revised Date: 2009-11-18 |
Medline Journal Info:
|
Nlm Unique ID: 0372673 Medline TA: Br Med J Country: ENGLAND |
Other Details:
|
Languages: eng Pagination: 14-6 Citation Subset: AIM; IM |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adrenergic beta-Antagonists
/
adverse effects,
therapeutic use* Adult Antibodies, Antinuclear / analysis* Female Humans Hypertension / drug therapy, immunology* Male Methyldopa / adverse effects, therapeutic use* Middle Aged |
| Chemical | |
Reg. No./Substance:
|
0/Adrenergic beta-Antagonists; 0/Antibodies, Antinuclear; 555-30-6/Methyldopa |
| Comments/Corrections | |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: The effect of temperature on the motility and viability of sperm.
Next Document: Further studies on the cardiolipin phosphodiesterase of Escherichia coli.